Exploring Clinical Innovation: A New Blog Series
We are happy to announce a new blog series created in collaboration between the Sarcoma Patient Advocacy Global Network (SPAGN) and the STREXIT 2 Project. In 2026, the series will explore key topics in clinical research, including international collaboration in rare cancer research, the role of Horizon Europe in driving innovation, the integration of real-world […]
The objectives of the STREXIT 2 Project in the words of Principal Investigator and Co-Leader Dr Winan van Houdt
STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme as part of the EU Mission on Cancer. The twelve clinical trials, led by multistakeholder and multidisciplinary consortiums, form together the European Cancer Cluster.
Introducing the Clinical Trial leaders of the STREXIT2 Project
Over the last couple of months, we introduced the people and organisations behind the STREXIT2 Project on our social media platforms. In this article, we will focus on the project’s clinical trial leader, Prof. Dr Alessandro Gronchi and the clinical trial co-leader, Dr Winan van Houdt. Dr Alessandro Gronchi, MD, graduated with high honours from […]
